Carl Zeiss Meditec AG (STU:AFXA) Shares Outstanding (Basic Average): 82 Mil (As of Dec. 2025)


STU:AFXA Carl Zeiss Meditec AG STU:AFXA
68 GF Score
Price €26.20
GF Value €71.57
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG Shares Outstanding (Basic Average)?

Carl Zeiss Meditec AG STU:AFXA -1.50% 68 Shares Outstanding (Basic Average) is 82 Mil as of Dec. 2025. GuruFocus rates STU:AFXA with a GF Score™ of 68/100 and a GF Value™ of €71.57 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Carl Zeiss Meditec AG's average basic shares outstanding for the quarter that ended in Dec. 2025 was 82 Mil.


Carl Zeiss Meditec AG  (STU:AFXA) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Carl Zeiss Meditec AG Shares Outstanding (Basic Average) Related Terms


Carl Zeiss Meditec AG Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Carl Zeiss Meditec AG's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG Shares Outstanding (Basic Average) Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.44 89.44 89.44 88.85 87.54

Carl Zeiss Meditec AG Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.22 87.18 88.58 87.20 81.67
STU:AFXA
68GF Score
Carl Zeiss Meditec AG STU:AFXA
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carl Zeiss Meditec AG Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 82 Mil mean?
Carl Zeiss Meditec AG (STU:AFXA) has a Shares Outstanding (Basic Average) of 82 Mil as of Dec. 2025. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Carl Zeiss Meditec AG and its competitors.
Is Carl Zeiss Meditec AG's Shares Outstanding (Basic Average) too high?
Carl Zeiss Meditec AG's current Shares Outstanding (Basic Average) is 82 Mil. Overall, Carl Zeiss Meditec AG has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Shares Outstanding (Basic Average) compare to ISRG and BDX?
Carl Zeiss Meditec AG's Shares Outstanding (Basic Average) of 82 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Medical Devices & Instruments company?
A good Shares Outstanding (Basic Average) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Carl Zeiss Meditec AG and its competitors. Carl Zeiss Meditec AG's current Shares Outstanding (Basic Average) is 82 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG (STU:AFXA) is currently considered Significantly Undervalued. The stock's GF Value™ is €71.57, compared to a current price of €26.20 — trading 63.4% below its estimated fair value. The current Shares Outstanding (Basic Average) is 82 Mil. Carl Zeiss Meditec AG's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Carl Zeiss Meditec AG (STU:AFXA), the current Shares Outstanding (Basic Average) is 82 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carl Zeiss Meditec AG (STU:AFXA) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of €26.20 is trading 63.4% below its estimated GF Value™ of €71.57. GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.

Key valuation signals for STU:AFXA:

  • Shares Outstanding (Basic Average): 82 Mil
  • GF Value™: €71.57 vs. price of €26.20 (63.4% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the STU:AFXA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
68GF Score

Get the complete analysis for STU:AFXA

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.20
Price
€71.57
GF Value